Asset Details
Do you wish to reserve the book?
Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control
Do you wish to request the book?
Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control
2024
Overview
Influenza A virus (IAV) can cause severe respiratory infection leading to significant global morbidity and mortality through seasonal epidemics. Likewise, the constantly increasing number of cancer diseases is a growing problem. Nevertheless, the understanding of the mutual interactions of the immune responses between cancer and infection is still very vague. Therefore, it is important to understand the immunological cross talk between cancer and IAV infection. In several preclinical mouse models of cancer, including melanoma and colorectal cancer, we observed that IAV infection in the lung significantly decreased the tumour burden. Concomitantly, tumour-specific CD8 + T-cells are strongly activated upon infection, both in the tumour tissue and in the lung. CD8 + T-cell depletion during infection reverses the reduced tumour growth. Interestingly, IAV infection orchestrated the migration of tumour-specific CD8 + T-cells from the tumour into the infected lung. Blocking the migration of CD8 + T-cells prevented the anti-tumoural effect. Thus, our findings show that viral respiratory infection has significant impact on the anti-tumour CD8 + T-cell response, which will significantly improve our understanding of the immunological cross talk between cancer and infection.
